Effect of extending the oral administration period of 5‐aminolevulinic acid on diagnostic accuracy and treatment outcomes for non–muscle‐invasive bladder cancer

The clinical efficacy of ALA-PDD, in terms of sensitivity and recurrence, was maintained even when the 5-ALA administration time was extended from 2 to 4 h to 2-8 h prior to TURBT.